Elevai Labs (ELAB) said Thursday that its Elevai Biosciences subsidiary filed two patent applications for its lead candidate, EL-22, to treat muscle loss in obese patients.
Shares surged 52% as intraday trading volume soared to over 477.4 million from a daily average of about 4.9 million.
EVgo (EVGO) said Thursday it has received a conditional commitment for a loan guarantee of up to $1.05 billion from the US Department of Energy to expand its fast charging network.
Shares soared 59% as intraday trading volume catapulted to more than 100.2 million from a daily average of about 3.39 million.
RBC Capital raised its price target on Vistra (VST) to $141 from $105 while keeping its outperform rating.
Shares of Vistra climbed 6.8%, with intraday trading volume at over 10.3 million compared with a daily average of about 6.9 million.
Price: 0.13, Change: +0.04, Percent Change: +51.53
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.